Перейти к основному содержанию
AkademIndex

Продукты

Для разработчиков

AkademBaseОткрытый API экосистемы
Статья

“When Treatment Is More Challenging than the Disease”: A Qualitative Study of MDR-TB Patient Retention

Kalpita ShringarpureDepartment of Preventive Social Medicine, Medical College, Baroda, IndiaPetros IsaakidisKaruna D. SagiliThe Union, South East Asia Office, New Delhi, IndiaR. K. BaxiDepartment of Preventive Social Medicine, Medical College, Baroda, IndiaMrinalini DasAmrita DaftaryCentre for the AIDS Programme of Research in South Africa (CAPRISA), Nelson R. Mandela School of Medicine, University of Kwazulu Natal, Durban, South Africa
2016en
ABI

Аннотация

BACKGROUND: One-fifth of the patients on multidrug-resistant tuberculosis treatment at the Drug-Resistant-TB (DR-TB) Site in Gujarat are lost-to-follow-up(LFU). OBJECTIVE: To understand patients' and providers' perspectives on reasons for LFU and their suggestions to improve retention-in-care. DESIGN: Qualitative study conducted between December 2013-March 2014, including in-depth interviews with LFU patients and DOT-providers, and a focus group discussion with DR-TB site supervisors. A thematic-network analysis approach was utilised. RESULTS: Three sub-themes emerged: (i) Struggle with prolonged treatment; (ii) Strive against stigma and toward support; (iii) Divergent perceptions and practices. Daily injections, pill burden, DOT, migratory work, social problems, prior TB treatment, and adverse drugs effects were reported as major barriers to treatment adherence and retention-in-care by patients and providers. Some providers felt that despite their best efforts, LFU patients remain. Patient movements between private practitioners and traditional healers further influenced LFU. CONCLUSION: The study points to a need for repeated patient counselling and education, improved co-ordination between various tiers of providers engaged in DR-TB care, collaboration between the public, private and traditional practitioners, and promotion of social and economic support to help patients adhere to MDR-TB treatment and avoid LFU.

Перевод пока недоступен

Идентификаторы

Цитирования и источники

Цитирований: 3Использованных источников: 0